JONATHAN T MD LORD
CIK 1112980 · Sr VP & Chief Innovation Off. · last filed 2023-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$36.79M
Companies
4
Total Filings
70
Lifetime Open-Market Net
-$16.84M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOLASE, INC (BIOL) Delisted | Director | 599 | $0.02 | $10 | $391.9K | 29 | 2023-06-12 |
| DXCM | Director | 211,280 | $70.48 | $14.89M | -$8.55M | 18 | 2016-09-06 |
| STERICYCLE INC (SRCL) Delisted | Director | 6,140 | $61.98 | $380.6K | -$2.34M | 12 | 2013-07-02 |
| HUM | Sr VP & Chief Innovation Off. | 55,507 | $394.50 | $21.90M | -$6.33M | 9 | 2009-05-06 |
Recent Filings · Page 2 of 7
70 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-20 | BIOLASE, INC (BIOL) Delisted | Buy (P) | +10,000 | $13.6K | EDGAR |
| 2018-08-14 | BIOLASE, INC (BIOL) Delisted | Buy (P) | +100,000 | $131.1K | EDGAR |
| 2018-05-14 | BIOLASE, INC (BIOL) Delisted | Mixed | +7,042 | $0 | EDGAR |
| 2017-12-06 | BIOLASE, INC (BIOL) Delisted | Exer (X) | +100,000 | $45.6K | EDGAR |
| 2017-11-09 | BIOLASE, INC (BIOL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-13 | BIOLASE, INC (BIOL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-03 | BIOLASE, INC (BIOL) Delisted | Conv (C) | +76,800 | $95.2K | EDGAR |
| 2017-05-12 | BIOLASE, INC (BIOL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-10 | BIOLASE, INC (BIOL) Delisted | Exer (M) | +50,000 | $0 | EDGAR |
| 2017-04-19 | BIOLASE, INC (BIOL) Delisted | Buy (P) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.